Healthgen Biotech attended the Vaccine World Summit India 2014
Wuhan Healthgen Biotechnology Corp.(Healthgen Biotech) attended the Vaccine World Summit India 2014 at Hyderabad International Convention Centre, India in 4-6 March. Our booth was located in Hall 2.
The Vaccine World Summit is the most sought after vaccine conference for India and rest of the developing country manufacturers. This summit gathered vaccine manufacturers, vaccine biotechs, investors, regulators, CRO and technology companies.
Healthgen Biotech attended the summit with the Rice Endosperm Specific Expression Platform–OryzHiExp, which independent researched and innovated by itself and its recombinant protein products expressed and produced by the OryzHiExp. OryzHiExp uses rice endosperm cells as biological reactor to high-efficiency express various types of protein. All of them are animal-free, with higher purity and better batch stability compare with the plasma-derived proteins. Provide a safer choice of serum free medium of vaccine.
Meanwhile, recombinant proteins can be used as excipient, stabilizer or embedding medium of vaccine during the production. Rice-derived recombinant proteins play a vital role in the aspects of speed up the development of vaccine industry and improve biological safety.
At our booth, we exhibited the animal-free recombinant proteins and peptides for cell culture:
Recombinant Human Serum Albumin, cell culture grade OsrHSA
Recombinant Human basic Fibroblast Growth Factor, OsrhbFGF
Recombinant Human Lactoferrin, OsrhLF
Recombinant Human Insulin-like Growth Factor-1 LR3, OsrhIGF-1 LR3
Rice endosperm cells biological reactor has the advantage of high expression quantity, low cost, scale easily, simple processing technology, eco-friendly and excellent security. Healthgen Biotech will make full use of the patented technology platform (Rice Endosperm-Specific Expression Platform, OryzHiExp to offer outsourcing, cooperation and other high quality technical services for the partners in the field of biotech.
